INVESTMENT STRATEGY – A BALANCED PORTFOLIO
Medical Services Sector , [ VALUE ]
R & D Sector , [ VALUE ]
Approximately 40 % of capital to be deployed in medical technologies , bioscience and research and development intensive companies (“ R & D Sector ”) including the following sub-sectors :
• Drug development
• Innova + ve medical devices and equipment
• Healthcare supplements and natural remedies
Approximately 60 % of capital to be deployed in consumer-centric medical services sectors (“ Medical Services Sector ”) including the following sub-sectors :
• Pharmaceu + cal produc + on and distribu + on
• Hospital & clinics and pharmacy chains
• Healthcare services that support the healthcare system